Ad-hoc | 26 March 2012 13:37


Eckert & Ziegler to Recommend Dividend Payment

Eckert & Ziegler Strahlen- und Medizintechnik AG  / Key word(s): Dividend

26.03.2012 13:37

Dissemination of an Ad hoc announcement according to § 15 WpHG, transmitted
by DGAP - a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.

---------------------------------------------------------------------------

Berlin, 26 March 2012. The company Eckert & Ziegler Strahlen- und
Medizintechnik AG (ISIN DE0005659700) achieved a series of jumps in
earnings, some considerable, in the financial year 2011. As the Supervisory
Board stated at its balance sheet meeting held today, the group's EBITDA
rose by 15% to 30 million EUR, EBIT by 38% to around 23 million EUR and the
profit per share by 9% to almost 2 EUR per share. At the General
Shareholders' Meeting to be held on 24 May 2012, the Executive Board and
the Supervisory Board will propose a dividend of 0.60 EUR per share
entitled to a dividend  (previous year: 0.60 EUR per share). The complete
figures will be published on 30 March 2012.

For enquiries please contact:
Eckert & Ziegler AG, Karolin Riehle, Investor Relations
Robert-Rössle-Str. 10, 13125 Berlin, Germany
Tel.: +49 (0) 30 / 94 10 84-138, karolin.riehle@ezag.de, www.ezag.com 


26.03.2012 DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de

---------------------------------------------------------------------------
 
Language:     English
Company:      Eckert & Ziegler Strahlen- und Medizintechnik AG
              Robert-Rössle-Str.10
              13125 Berlin
              Germany
Phone:        49 30 941084-138
Fax:          49 30 941084-112
E-mail:       karolin.riehle@ezag.de
Internet:     www.ezag.de
ISIN:         DE0005659700
WKN:          565970
Listed:       Regulierter Markt in Frankfurt (Prime Standard), Stuttgart;
              Freiverkehr in Berlin, Düsseldorf, Hamburg, München
 
End of Announcement                             DGAP News-Service
 
---------------------------------------------------------------------------